Cell and Gene Therapy Market Size to Reach USD 7,250.0 Million by 2028 | Increasing Investments in Production Capacity Expansion for Cell and Gene Therapy will be the Key Factor Driving the Industry Growth, States Emergen Research

The global cell and gene therapy market is forecasted to grow at a rate of 19.8% from USD 1,180.0 Million in 2019 to USD 6,570.0 Million in 2027

Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global cell and gene therapy market is projected to reach a market size of USD 7,250.0 Million by 2028 at a rapid and steady CAGR of 16.3% over the forecast period, according to most recent analysis by Emergen Research. The growing demand for cell and gene therapy can be attributed to increasing investments in production capacity expansion for cell and gene therapy. Several contract development & manufacturing organizations and contract manufacturing organizations are making huge investments in the expansion of cell and gene therapy production capacity, anticipating a rise in demand for their services from biopharmaceutical companies that emphasize the development and production of emerging therapeutic technologies.

For instance, in May 2019, CDMO Catalent invested USD 1.20 billion in Paragon Bioservices, a contract development & manufacturing organization involved in developing and producing viral vector development for gene therapy. In April 2019, Paragon Biosciences had commenced its second good manufacturing practices (GMP) gene therapy production facility in Harmans, Maryland, the US, to provide customized manufacturing set-ups to manage the specific requirements for gene therapy products.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/27

Key Highlights of Report

  • In October 2020, Bayer made an announcement about the acquisition of Asklepios BioPharmaceutical worth USD 4.00 Billion. The acquisition is intended to extend Bayer’s capacity and capability in cell and gene therapy production.
  • Automated whole genome sequencing technology is considered to be beneficial in improving the diagnosis and treatment of critically sick children, mostly infants, suffering from several genetic diseases.
  • In May 2019, the CRISPR gene-editing technology was used on a trial basis in the treatment of cancer, and researchers are hopeful about the positive benefits this technology in the treatment of other diseases, as well.
  • The use of gene therapy in kidney appropriated for transplantation purposes is beneficial in treating acute rejection, ischemia reperfusion, and chronic allograft nephropathy. Besides, the use of hybrid stem cell-gene therapy technology is helpful in promoting renal disease gene therapy toward clinical application.
  • Cell and gene therapy lentivirus vectors provide several unique benefits than conventional retroviral vectors. Lentivirus vectors are capable of offering lasting stable gene expression and transducing non-dividing cells, including neurons.
  • Cell and gene therapy market in Europe held the second largest revenue share in 2020, owing to the presence of leading biopharmaceutical firms and growing investments in R&D activities and production capacity expansion in the region.
  • Major companies operating in the global cell and gene therapy market include Spark Therapeutics LLC, Novartis AG, Gilead Sciences Inc., Bluebird Bio, GlaxoSmithKline, Celgene Corporation, Shire PLC, Sangamo Biosciences, Voyager Therapeutics, and Dimension Therapeutics.

Check Our Prices@ https://www.emergenresearch.com/select-license/27
Emergen Research has segmented the global cell and gene therapy market in terms of indication, vector type, and region:

  • Indication Outlook (Revenue, USD Billion; 2018-2028)
    • Acute Lymphoblastic Leukemia (ALL)
    • Inherited Retinal Disease
    • Large B-Cell Lymphoma
    • ADA-SCID
    • Others
  • Vector Outlook (Revenue, USD Billion; 2018-2028)
    • Lentivirus
    • AAV
    • Retrovirus & Gammaretrovirus
    • Modified Herpes Simplex Virus
    • Adenovirus
    • Non-Viral Plasmid Vector

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   http://www.emergenresearch.com/industry-report/cell-and-gene-therapy-market

  • Regional Outlook (Revenue, USD Million; 2018–2028)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of Middle East & Africa

Take a Look at our Related Reports:

AI-Enabled Medical Imaging Solutions Market By Product (Software, Hardware), By Workflow (Image Acquisition, Image Analysis, Reporting, and Communication), By Therapeutic Application (General Imaging, Specialty Imaging), By Deployment Mode, By Modality, and By Region, Forecasts to 2027

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ http://www.emergenresearch.com/press-release/global-cell-and-gene-therapy-market